Market Overview

Benzinga's Top #PreMarket Losers

Share:
Related
Bank Of America Upgrades Sarepta Therapeutics On 'Increased Conviction' Of Drug Approval
Mid-Day Market Update: Starwood Hotels Jumps Following CEO Resignation; CoStar Group Shares Slide
Sarepta Therapeutics' (SRPT) CEO Chris Garabedian on Q4 2014 Results -- Earnings Call Transcript (Seeking Alpha)
Related HSOL
Wild Swings In Solar Short Interest
US Stock Futures Point To Lower Open Monday

Sarepta Therapeutics (NASDAQ: SRPT) dipped 48.69% to $18.76 in the pre-market session. Sarepta reported a non-GAAP net loss of $21.3 million, or $0.63 per share. Piper Jaffray downgraded the stock from Overweight to Underweight.

Hanwha SolarOne Co (NASDAQ: HSOL) shares dropped 14.43% to $4.33 in pre-market trading on Q3 results.

Hologic (NASDAQ: HOLX) shares fell 12.66% to $20.00 in the pre-market trading after the company issued downbeat outlook for fiscal 2014. Canaccord Genuity downgraded the stock from Buy to Hold.

JA Solar Holdings Co (NASDAQ: JASO) dipped 3.89% to $11.60. JA Solar's trailing-twelve-month ROE is -24.62%.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (HOLX + HSOL)

Around the Web, We're Loving...

Get Benzinga's Newsletters